BROCK HIGGS: Open Payments
NPI 1487305868 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 25 payments from 7 companies in 2025. Trend: 2023 $315 · 2024 $253 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $174 |
| Amgen Inc. | 5 | $91 |
| Calliditas Therapeutics US Inc. | 2 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| ANI Pharmaceuticals, Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Fresenius USA Marketing, Inc. | 1 | $18 |
Products named: TAVNEOS, TARPEYO, JARDIANCE, PURIFIED CORTROPHIN GEL, LOKELMA, KRYSTEXXA, VELPHORO.
Industry payments across UT — which companies pay providers there.
